Prognoses of Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy before Surgery: A Retrospective Analysis

SIMPLE SUMMARY: To date there is no specific analysis providing comprehensive available evidence that can guide clinical treatment options for patients with hormone receptor-positive and human epidermal growth factor receptor-2-negative (HR+/HER2−) breast cancer (BC) after neoadjuvant chemotherapy (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shichao, Liu, Yan, Liu, Xu, Liu, Yingxue, Zhang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953770/
https://www.ncbi.nlm.nih.gov/pubmed/36831499
http://dx.doi.org/10.3390/cancers15041157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953770/
https://www.ncbi.nlm.nih.gov/pubmed/36831499
http://dx.doi.org/10.3390/cancers15041157

Ejemplares similares